首页 > 市场调查报告书 > 医疗设备

市场调查报告书

商品编码

2008955

神经系统医疗设备市场报告：按产品、最终用户和地区划分（2026-2034 年）

Neurology Devices Market Report by Product, End User, and Region 2026-2034

出版日期: 2026年04月01日 | 出版商:

IMARC | 英文 136 Pages | 商品交期: 2-3个工作天内

价格

简介目录图表

2025年，全球神经医疗设备市场规模达154亿美元。展望未来，IMARC集团预测，到2034年，该市场规模将达到268亿美元，2026年至2034年的复合年增长率（CAGR）为6.20%。推动市场成长的因素多种多样，包括癫痫、阿兹海默症、失智症和脑血管疾病等各种神经系统疾病的盛行率不断上升，技术进步带来的改良型医疗器材的推出，以及老年人口的成长。

神经系统医疗设备市场趋势：

神经系统疾病盛行率增加

根据世界卫生组织（世卫组织）的数据，2021年全球有2.06亿人患有糖尿病神经病变。人们饱受多种神经系统疾病的折磨，这些疾病的原因包括遗传性疾病、感染疾病、先天缺陷、文明病（如营养不良）以及脑部、脊髓和神经损伤。这些疾病对患者的生活造成负面影响，导致协调能力受损、肌肉无力、感觉障碍等问题。此外，患者对有效可靠解决方案的需求日益增长，推动了神经系统设备的需求。这些设备能够对大脑活动和结构进行详细的可视化和监测，从而实现对神经系统疾病的精准诊断。

由于技术进步，改良型设备得以引入

主要企业正致力于推出融合创新技术、能够改善病患照护的医疗设备。这些企业提供的设备具备远端医疗患者监测。例如，2022年4月25日，雅培发布了其数位健康应用程式NeuroSphere™ myPath™的新版本。此版本包含多项功能，使医生能够更密切地监测患者。在使用背根神经节（DRG）或脊髓刺激（SCS）治疗设备时，患者、医生和医疗团队可以在治疗过程的每个阶段，透过该数位健康应用程式共同查看患者报告的疗效指标。

老年人口增加

全球老年人口的不断增长为神经医疗设备市场带来了光明的前景。老年人由于更容易患上失智症、中风、帕金森氏症和阿兹海默症神经系统疾病，因此对神经医疗设备的需求日益增长。随着老年人需要更多医疗护理，且神经系统疾病的盛行率也更高，对神经系统服务和医疗用品的需求也不断增加。世界卫生组织（世卫组织）预测，到2050年，80岁以上人口数将达到4.26亿。

The global neurology devices market size reached USD 15.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 26.8 Billion by 2034, exhibiting a growth rate (CAGR) of 6.20% during 2026-2034. There are various factors that are driving the market, which include increasing prevalence of various neurological disorders like epilepsy, Alzheimer's disease, dementias, and cerebrovascular diseases, introduction of improved devices due to technological advancements, and rising geriatric population.

NEUROLOGY DEVICES MARKET ANALYSIS:

Major Market Drivers: One of the key market drivers is favorable government initiatives. Moreover, the expansion of healthcare facilities is acting as a growth-inducing factor.
Key Market Trends: The market demand is propelled, owing to numerous primary trends, which include rising incidences of various neurological disorders and the increasing geriatric population.
Geographical Trends: According to the report, North America exhibits a clear dominance, accounting for the largest market share on account of the presence of advanced healthcare facilities.
Competitive Landscape: Some of the major market players in the neurology devices industry are Abbott, B. Braun SE, Boston Scientific Corporation, Integra LifeSciences Corporation, LivaNova PLC, Medtronic plc, Natus Medical Incorporated, Nihon Kohden Corporation, Penumbra, Inc, and Stryker Corporation, among many others.
Challenges and Opportunities: One of the key challenges hindering the market growth are regulatory hurdles. On the other hand, advancements in regenerative medicine and restorative therapies represent recent opportunities.

NEUROLOGY DEVICES MARKET TRENDS:

Increasing Prevalence of Neurological Disorders

According to the World Health Organization (WHO), the number of people with diabetic neuropathy was 206 Million in 2021. People are suffering from numerous neurological disorders on account of genetic disorders, infections, congenital abnormalities, lifestyle health problems including malnutrition, and brain, spinal cord, and nerve injury. These diseases have a negative impact on the life of individuals like poor coordination, muscle weakness, and loss of sensation. In addition, the rising need for effective and reliable solutions among patients is catalyzing the neurology device demand. These devices enable precise diagnosis of neurological conditions by allowing detailed visualization and monitoring of brain activity and structure.

Introduction of Improved Devices Due to Technological Advancements

Key players are focusing on introducing devices that have innovative technologies and can provide enhanced care to patients. They are offering devices that have telemedicine capabilities and allow for remote monitoring of patients. For example, Abbott released a new edition of its NeuroSphere TM myPath TM digital health app on 25 April 2022. This version has more features that will allow physicians to monitor their patients more carefully. While using a dorsal root ganglion (DRG) or spinal cord stimulation (SCS) therapy device, the patient, a doctor, and their team can view patient-reported outcome measurements together on a digital health app at every point of the treatment process.

Rising Geriatric Population

The increasing number of geriatric populations across the globe is offering a positive neurology devices market outlook. Owing to their increased vulnerability to neurological conditions such as dementia, stroke, Parkinson's disease, and Alzheimer's disease, older persons are becoming more and more in need of neurology equipment. Elderly people require more medical attention, and as neurological issues are more prevalent in this age group, there is a greater need for neurology services and supplies. The World Health Organization (WHO) projects that the number of persons aged 80 years or older is expected to reach 426 Million in 2050.

NEUROLOGY DEVICES MARKET SEGMENTATION:

Breakup by Product:

Neurostimulation Devices
Neurosurgery Devices
Interventional Neurology Devices
Cerebrospinal Fluid Management Devices
Others

Neurostimulation devices account for the majority of the market share

Neurostimulation devices play a crucial role in stimulating nerves and regulating faulty neural pathway behavior arising from the disease process by means of medication, electrical signals, or energy. They provide a customized approach to managing the patient's condition and can be adjusted to meet the needs of the individual. Neurostimulation offers an alternative that may reduce the need for medication or dosage for those who depend on it to control their symptoms. Additionally, these tools can help with focus, cognitive enhancement, better sleep, less stress, and treatment of conditions including depression, migraines, anxiety, and insomnia, which is contributing to the neurology devices market growth. Moreover, big players in the market are introducing new products and receiving money from authorities to enhance patient care. For instance, on 08 January 2024, the US FDA approved Medtronic plc's PerceptTM RC deep brain stimulation (DBS) system. The rechargeable neurostimulator is the newest member of the Medtronic PerceptTM family, which also includes the PerceptTM PC neurostimulator, BrainSenseTM technology, and SenSightTM directional leads. Individualized treatment plans can be created for patients with movement disorders such as essential tremor, dystonia, Parkinson's disease, and epilepsy using the only sensing-enabled DBS device in the PerceptTM family.

Breakup by End User:

Hospitals
Ambulatory Surgery Centers
Neurology Clinics

Hospitals hold the largest share of the industry

In 2021, there were approximately 165,000 hospitals worldwide, according to DiscoveryABATherapy. Hospitals are outfitted to offer full medical care, including sophisticated neurological disorder treatments, emergency services, and advanced diagnostics. As a result, they serve as the main locations for the use of various neurology devices. Furthermore, hospitals can accommodate a greater number of patients including those with neurological disorders as compared to other types of healthcare institutions. The need for neurology equipment in these settings is driven by the increased patient influx. These facilities also feature the infrastructure required to handle advanced neurological devices, as well as specialist medical personnel like neurologists, neurosurgeons, and specialized nursing care. This includes wards designed specifically for post-operative care and monitoring and operating rooms furnished for neurosurgery procedures.

Breakup by Region:

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

North America leads the market, accounting for the largest neurology devices market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for neurology devices.

North America has modern medical technologies with state-of-the-art healthcare institutions. The region's medical research institutes are concentrating on research and development (R&D) endeavors, as these operations foster innovation and lead to the release of new neurological equipment onto the market. Apart from this, the market expansion is being aided by favorable government efforts in North America. Moreover, the high prevalence of neurological disorders among the North American population necessitates robust healthcare solutions. The need for neurology equipment in the region is fueled by their vital role in the management and treatment of various illnesses. As per the Alzheimer's Association, there were will be around13 Million Americans that will suffer from Alzheimer's disease by 2050.

Competitive Landscape:

Top companies in neurology devices industry are forming strategic mergers and acquisitions (M&As), partnerships, and collaborations to expand their product portfolios and geographical reach. They are creating novel and inventive products with improved efficacy and safety by investing in R&D activities. Additionally, companies are expanding their operations globally to tap into emerging markets where there is a growing awareness of neurological diseases and an increasing capability to spend on advanced medical treatments. This includes establishing production facilities or sales offices in new areas, which will also benefit in increasing their neurology devices market revenue. To remain competitive in the market, they are also launching new items and updating old ones. For instance, Abbott introduced its NeuroSphereTM Virtual Clinic in the United States on 8 March 2021. This innovative technology enables patients to interact with doctors, guarantee optimal settings and functionality, and obtain new treatment settings from a distance. Approved by the U.S. Food and Drug Administration (FDA), the NeuroSphere Virtual Clinic can increase access to optimal treatment for patients suffering from chronic pain or movement disorders.

The report provides a comprehensive analysis of the competitive landscape in the global neurology devices market with detailed profiles of all major companies, including:

Abbott
B. Braun SE
Boston Scientific Corporation
Integra LifeSciences Corporation
LivaNova PLC
Medtronic plc
Natus Medical Incorporated
Nihon Kohden Corporation
Penumbra, Inc
Stryker Corporation

KEY QUESTIONS ANSWERED IN THIS REPORT

1. What was the size of the global neurology devices market in 2025?

2. What is the expected growth rate of the global neurology devices market during 2026-2034?

3. What are the key factors driving the global neurology devices market?

4. What has been the impact of COVID-19 on the global neurology devices market?

5. What is the breakup of the global neurology devices market based on the product?

6. What is the breakup of the global neurology devices market based on the end user?

7. What are the key regions in the global neurology devices market?

8. Who are the key players/companies in the global neurology devices market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Neurology Devices Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product

6.1 Neurostimulation Devices
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Neurosurgery Devices
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Interventional Neurology Devices
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Cerebrospinal Fluid Management Devices
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
6.5 Others
- 6.5.1 Market Trends
- 6.5.2 Market Forecast

7 Market Breakup by End User

7.1 Hospitals
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Ambulatory Surgery Centers
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Neurology Clinics
- 7.3.1 Market Trends
- 7.3.2 Market Forecast

8 Market Breakup by Region

8.1 North America
- 8.1.1 United States
  - 8.1.1.1 Market Trends
  - 8.1.1.2 Market Forecast
- 8.1.2 Canada
  - 8.1.2.1 Market Trends
  - 8.1.2.2 Market Forecast
8.2 Asia-Pacific
- 8.2.1 China
  - 8.2.1.1 Market Trends
  - 8.2.1.2 Market Forecast
- 8.2.2 Japan
  - 8.2.2.1 Market Trends
  - 8.2.2.2 Market Forecast
- 8.2.3 India
  - 8.2.3.1 Market Trends
  - 8.2.3.2 Market Forecast
- 8.2.4 South Korea
  - 8.2.4.1 Market Trends
  - 8.2.4.2 Market Forecast
- 8.2.5 Australia
  - 8.2.5.1 Market Trends
  - 8.2.5.2 Market Forecast
- 8.2.6 Indonesia
  - 8.2.6.1 Market Trends
  - 8.2.6.2 Market Forecast
- 8.2.7 Others
  - 8.2.7.1 Market Trends
  - 8.2.7.2 Market Forecast
8.3 Europe
- 8.3.1 Germany
  - 8.3.1.1 Market Trends
  - 8.3.1.2 Market Forecast
- 8.3.2 France
  - 8.3.2.1 Market Trends
  - 8.3.2.2 Market Forecast
- 8.3.3 United Kingdom
  - 8.3.3.1 Market Trends
  - 8.3.3.2 Market Forecast
- 8.3.4 Italy
  - 8.3.4.1 Market Trends
  - 8.3.4.2 Market Forecast
- 8.3.5 Spain
  - 8.3.5.1 Market Trends
  - 8.3.5.2 Market Forecast
- 8.3.6 Russia
  - 8.3.6.1 Market Trends
  - 8.3.6.2 Market Forecast
- 8.3.7 Others
  - 8.3.7.1 Market Trends
  - 8.3.7.2 Market Forecast
8.4 Latin America
- 8.4.1 Brazil
  - 8.4.1.1 Market Trends
  - 8.4.1.2 Market Forecast
- 8.4.2 Mexico
  - 8.4.2.1 Market Trends
  - 8.4.2.2 Market Forecast
- 8.4.3 Others
  - 8.4.3.1 Market Trends
  - 8.4.3.2 Market Forecast
8.5 Middle East and Africa
- 8.5.1 Market Trends
- 8.5.2 Market Breakup by Country
- 8.5.3 Market Forecast

9 SWOT Analysis

9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
- 13.3.1 Abbott
  - 13.3.1.1 Company Overview
  - 13.3.1.2 Product Portfolio
  - 13.3.1.3 Financials
  - 13.3.1.4 SWOT Analysis
- 13.3.2 B. Braun SE
  - 13.3.2.1 Company Overview
  - 13.3.2.2 Product Portfolio
  - 13.3.2.3 SWOT Analysis
- 13.3.3 Boston Scientific Corporation
  - 13.3.3.1 Company Overview
  - 13.3.3.2 Product Portfolio
  - 13.3.3.3 Financials
  - 13.3.3.4 SWOT Analysis
- 13.3.4 Integra LifeSciences Corporation
  - 13.3.4.1 Company Overview
  - 13.3.4.2 Product Portfolio
  - 13.3.4.3 Financials
  - 13.3.4.4 SWOT Analysis
- 13.3.5 LivaNova PLC
  - 13.3.5.1 Company Overview
  - 13.3.5.2 Product Portfolio
  - 13.3.5.3 Financials
- 13.3.6 Medtronic plc
  - 13.3.6.1 Company Overview
  - 13.3.6.2 Product Portfolio
  - 13.3.6.3 Financials
  - 13.3.6.4 SWOT Analysis
- 13.3.7 Natus Medical Incorporated
  - 13.3.7.1 Company Overview
  - 13.3.7.2 Product Portfolio
  - 13.3.7.3 Financials
  - 13.3.7.4 SWOT Analysis
- 13.3.8 Nihon Kohden Corporation
  - 13.3.8.1 Company Overview
  - 13.3.8.2 Product Portfolio
  - 13.3.8.3 Financials
  - 13.3.8.4 SWOT Analysis
- 13.3.9 Penumbra, Inc
  - 13.3.9.1 Company Overview
  - 13.3.9.2 Product Portfolio
  - 13.3.9.3 Financials
- 13.3.10 Stryker Corporation
  - 13.3.10.1 Company Overview
  - 13.3.10.2 Product Portfolio
  - 13.3.10.3 Financials
  - 13.3.10.4 SWOT Analysis

简介目录图表

List of Figures

Figure 1: Global: Neurology Devices Market: Major Drivers and Challenges
Figure 2: Global: Neurology Devices Market: Sales Value (in Billion USD), 2020-2025
Figure 3: Global: Neurology Devices Market Forecast: Sales Value (in Billion USD), 2026-2034
Figure 4: Global: Neurology Devices Market: Breakup by Product (in %), 2025
Figure 5: Global: Neurology Devices Market: Breakup by End User (in %), 2025
Figure 6: Global: Neurology Devices Market: Breakup by Region (in %), 2025
Figure 7: Global: Neurology Devices (Neurostimulation Devices) Market: Sales Value (in Million USD), 2020 & 2025
Figure 8: Global: Neurology Devices (Neurostimulation Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 9: Global: Neurology Devices (Neurosurgery Devices) Market: Sales Value (in Million USD), 2020 & 2025
Figure 10: Global: Neurology Devices (Neurosurgery Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 11: Global: Neurology Devices (Interventional Neurology Devices) Market: Sales Value (in Million USD), 2020 & 2025
Figure 12: Global: Neurology Devices (Interventional Neurology Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 13: Global: Neurology Devices (Cerebrospinal Fluid Management Devices) Market: Sales Value (in Million USD), 2020 & 2025
Figure 14: Global: Neurology Devices (Cerebrospinal Fluid Management Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 15: Global: Neurology Devices (Other Products) Market: Sales Value (in Million USD), 2020 & 2025
Figure 16: Global: Neurology Devices (Other Products) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 17: Global: Neurology Devices (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
Figure 18: Global: Neurology Devices (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 19: Global: Neurology Devices (Ambulatory Surgery Centers) Market: Sales Value (in Million USD), 2020 & 2025
Figure 20: Global: Neurology Devices (Ambulatory Surgery Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 21: Global: Neurology Devices (Neurology Clinics) Market: Sales Value (in Million USD), 2020 & 2025
Figure 22: Global: Neurology Devices (Neurology Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 23: North America: Neurology Devices Market: Sales Value (in Million USD), 2020 & 2025
Figure 24: North America: Neurology Devices Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 25: United States: Neurology Devices Market: Sales Value (in Million USD), 2020 & 2025
Figure 26: United States: Neurology Devices Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 27: Canada: Neurology Devices Market: Sales Value (in Million USD), 2020 & 2025
Figure 28: Canada: Neurology Devices Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 29: Asia-Pacific: Neurology Devices Market: Sales Value (in Million USD), 2020 & 2025
Figure 30: Asia-Pacific: Neurology Devices Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 31: China: Neurology Devices Market: Sales Value (in Million USD), 2020 & 2025
Figure 32: China: Neurology Devices Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 33: Japan: Neurology Devices Market: Sales Value (in Million USD), 2020 & 2025
Figure 34: Japan: Neurology Devices Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 35: India: Neurology Devices Market: Sales Value (in Million USD), 2020 & 2025
Figure 36: India: Neurology Devices Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 37: South Korea: Neurology Devices Market: Sales Value (in Million USD), 2020 & 2025
Figure 38: South Korea: Neurology Devices Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 39: Australia: Neurology Devices Market: Sales Value (in Million USD), 2020 & 2025
Figure 40: Australia: Neurology Devices Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 41: Indonesia: Neurology Devices Market: Sales Value (in Million USD), 2020 & 2025
Figure 42: Indonesia: Neurology Devices Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 43: Others: Neurology Devices Market: Sales Value (in Million USD), 2020 & 2025
Figure 44: Others: Neurology Devices Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 45: Europe: Neurology Devices Market: Sales Value (in Million USD), 2020 & 2025
Figure 46: Europe: Neurology Devices Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 47: Germany: Neurology Devices Market: Sales Value (in Million USD), 2020 & 2025
Figure 48: Germany: Neurology Devices Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 49: France: Neurology Devices Market: Sales Value (in Million USD), 2020 & 2025
Figure 50: France: Neurology Devices Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 51: United Kingdom: Neurology Devices Market: Sales Value (in Million USD), 2020 & 2025
Figure 52: United Kingdom: Neurology Devices Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 53: Italy: Neurology Devices Market: Sales Value (in Million USD), 2020 & 2025
Figure 54: Italy: Neurology Devices Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 55: Spain: Neurology Devices Market: Sales Value (in Million USD), 2020 & 2025
Figure 56: Spain: Neurology Devices Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 57: Russia: Neurology Devices Market: Sales Value (in Million USD), 2020 & 2025
Figure 58: Russia: Neurology Devices Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 59: Others: Neurology Devices Market: Sales Value (in Million USD), 2020 & 2025
Figure 60: Others: Neurology Devices Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 61: Latin America: Neurology Devices Market: Sales Value (in Million USD), 2020 & 2025
Figure 62: Latin America: Neurology Devices Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 63: Brazil: Neurology Devices Market: Sales Value (in Million USD), 2020 & 2025
Figure 64: Brazil: Neurology Devices Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 65: Mexico: Neurology Devices Market: Sales Value (in Million USD), 2020 & 2025
Figure 66: Mexico: Neurology Devices Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 67: Others: Neurology Devices Market: Sales Value (in Million USD), 2020 & 2025
Figure 68: Others: Neurology Devices Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 69: Middle East and Africa: Neurology Devices Market: Sales Value (in Million USD), 2020 & 2025
Figure 70: Middle East and Africa: Neurology Devices Market: Breakup by Country (in %), 2025
Figure 71: Middle East and Africa: Neurology Devices Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 72: Global: Neurology Devices Industry: SWOT Analysis
Figure 73: Global: Neurology Devices Industry: Value Chain Analysis
Figure 74: Global: Neurology Devices Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Neurology Devices Market: Key Industry Highlights, 2025 and 2034
Table 2: Global: Neurology Devices Market Forecast: Breakup by Product (in Million USD), 2026-2034
Table 3: Global: Neurology Devices Market Forecast: Breakup by End User (in Million USD), 2026-2034
Table 4: Global: Neurology Devices Market Forecast: Breakup by Region (in Million USD), 2026-2034
Table 5: Global: Neurology Devices Market: Competitive Structure
Table 6: Global: Neurology Devices Market: Key Players

02-2729-4219

+886-2-2729-4219

License/价格

神经系统医疗设备市场报告：按产品、最终用户和地区划分（2026-2034 年）

Neurology Devices Market Report by Product, End User, and Region 2026-2034

神经系统医疗设备市场趋势：

目录

第一章：序言

第二章：调查方法

第三章执行摘要

第四章：引言

第五章：全球神经医疗设备市场

第六章 市场区隔：依产品划分

第七章 市场区隔：依最终用户划分

第八章 市场区隔：依地区划分

第九章 SWOT 分析

第十章：价值链分析

第十一章：波特五力分析

第十二章：价格分析

第十三章 竞争格局